These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26173007)

  • 41. A simulation study comparing the power of nine tests of the treatment effect in randomized controlled trials with a time-to-event outcome.
    Royston P; B Parmar MK
    Trials; 2020 Apr; 21(1):315. PubMed ID: 32252820
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Large sample tests for binary outcomes in fixed-dose combination drug studies.
    Wang SJ; Hung HM
    Biometrics; 1997 Jun; 53(2):498-503. PubMed ID: 9192448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selection of the effect size for sample size determination for a continuous response in a superiority clinical trial using a hybrid classical and Bayesian procedure.
    Ciarleglio MM; Arendt CD; Peduzzi PN
    Clin Trials; 2016 Jun; 13(3):275-85. PubMed ID: 26928986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Re-estimating sample size in cluster randomised trials with active recruitment within clusters.
    van Schie S; Moerbeek M
    Stat Med; 2014 Aug; 33(19):3253-68. PubMed ID: 24719285
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings.
    Bedard PL; Krzyzanowska MK; Pintilie M; Tannock IF
    J Clin Oncol; 2007 Aug; 25(23):3482-7. PubMed ID: 17687153
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blinded sample size recalculation in clinical trials incorporating historical data.
    Hees K; Kieser M
    Contemp Clin Trials; 2017 Dec; 63():2-7. PubMed ID: 28735110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blinded and unblinded internal pilot study designs for clinical trials with count data.
    Schneider S; Schmidli H; Friede T
    Biom J; 2013 Jul; 55(4):617-33. PubMed ID: 23703749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sample size calculations in acute stroke trials: a systematic review of their reporting, characteristics, and relationship with outcome.
    Weaver CS; Leonardi-Bee J; Bath-Hextall FJ; Bath PM
    Stroke; 2004 May; 35(5):1216-24. PubMed ID: 15031455
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MSurvPow: a FORTRAN program to calculate the sample size and power for cluster-randomized clinical trials with survival outcomes.
    Gao F; Manatunga AK; Chen S
    Comput Methods Programs Biomed; 2005 Apr; 78(1):61-7. PubMed ID: 15780890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Flexible two-stage design with sample size reassessment for survival trials.
    Desseaux K; Porcher R
    Stat Med; 2007 Nov; 26(27):5002-13. PubMed ID: 17577242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sample size calculations in randomised trials: mandatory and mystical.
    Schulz KF; Grimes DA
    Lancet; 2005 Apr 9-15; 365(9467):1348-53. PubMed ID: 15823387
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Demographic analysis of randomized controlled trials in bladder cancer.
    Bachir BG; Shariat SF; Zlotta A; Svatek R; Black PC; Shah JB; Kassouf W; ;
    BJU Int; 2013 Mar; 111(3):419-26. PubMed ID: 22928764
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The size of the chi-square test for the Hardy-Weinberg law.
    Kang SH; Shin D
    Hum Hered; 2004; 58(1):10-7. PubMed ID: 15604560
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Designing efficient randomized trials: power and sample size calculation when using semiparametric efficient estimators.
    Schuler A
    Int J Biostat; 2021 Aug; 18(1):151-171. PubMed ID: 34364314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Baseline characteristics and statistical power in randomized controlled trials: selection, prognostic targeting, or covariate adjustment?
    Roozenbeek B; Maas AI; Lingsma HF; Butcher I; Lu J; Marmarou A; McHugh GS; Weir J; Murray GD; Steyerberg EW;
    Crit Care Med; 2009 Oct; 37(10):2683-90. PubMed ID: 19885979
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimal conditional error functions for the control of conditional power.
    Brannath W; Bauer P
    Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increasing trial efficiency by early reallocation of placebo nonresponders in sequential parallel comparison designs: application to antidepressant trials.
    Boessen R; Knol MJ; Groenwold RH; Grobbee DE; Roes KC
    Clin Trials; 2012 Oct; 9(5):578-87. PubMed ID: 23060319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Statistical power and sample size requirements for three level hierarchical cluster randomized trials.
    Heo M; Leon AC
    Biometrics; 2008 Dec; 64(4):1256-62. PubMed ID: 18266889
    [TBL] [Abstract][Full Text] [Related]  

  • 59. On power and sample size calculation for QT studies with recording replicates at given time point.
    Chow SC; Cheng B; Cosmatos D
    J Biopharm Stat; 2008; 18(3):483-93. PubMed ID: 18470757
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of continuous versus dichotomous outcome variables on study power when sample sizes of orthopaedic randomized trials are small.
    Bhandari M; Lochner H; Tornetta P
    Arch Orthop Trauma Surg; 2002 Mar; 122(2):96-8. PubMed ID: 11880910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.